All Insights
Exploring the science, practice, and business of medicine.
Exploring the science, practice, and business of medicine.
Showing 10 out of 554 Insights
In this episode of Science Snapshot, learn how a new once-daily pill called daraxonrasib is nearly doubling median survival for previously treated metastatic pancreatic cancer patients.
MedEdPearls July 2026: Teaching for Moments of Resonance and Transformation
HealthSpark, Episode 19: Ariel Stern, Alexander von Humboldt Professor for Digital Health, Economics, and Policy at the Hasso Plattner Institute and Professor at the University of Potsdam, discusses why so many promising digital health tools fail to move beyond pilot projects and outlines the steps health systems, payers, and industry partners must take to integrate these solutions into routine care for patients and clinicians.
Health systems are embracing digital and AI innovations, but only those aligned with policy, payment, and operations will truly change how clinicians care for patients.
In this Harvard Macy Institute blog post, artificial intelligence and evidence-based medicine are discussed.
HealthSpark, Episode 18: Fatima Cody Stanford, an obesity medicine physician scientist at Massachusetts General Hospital and Harvard Medical School, explains why obesity is one of the most complex challenges in modern health care and explores what it will take to replace blame with evidence‑based, compassionate action.
HealthSpark, Episode 17: Elliott Antman, Cardiologist and Senior Physician at Brigham and Women's Hospital and Professor of Medicine at Harvard Medical School, examines how smartwatches and other consumer devices are redefining what patients notice and bring into the exam room, and how clinicians can use this data effectively.
As health care shifts toward value-based models, truly patient-centric care depends on training every type of learner to keep the patient’s voice and real-world needs at the center of their work.
HealthSpark, Episode 16: Leemore Dafny, an applied microeconomist and former Deputy Director for Health Care and Antitrust at the Federal Trade Commission, examines how private equity-driven consolidation is reshaping health care spending and market stability, and whether these deals serve the public interest by protecting access, affordability, quality, and competition.
Informed consent is an evolving, trust-building partnership between researchers and participants—one that goes far beyond a signature to ensure true understanding, respect autonomy, and navigate the growing ethical and technological complexities of modern clinical studies.